Drug recall D-1327-2015
Product
Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single dose vial. Manufactured by Fresenius Kabi USA 2020 N Ruby Street, Melrose Park, IL 60160-1112 for Fresenius Kabi USA, 3 Corporate Dr Lake Zurich, IL 60047-8930. NDC 63323-614-01
Reason for recall
Incorrect Expiration Date: The "11/06" expiration date printed on the tray (secondary packaging) is incorrect (it should be 11/2016)
Lots and codes
Lot #: 6110593, Exp 11/2016
Recall details
- Recalling firm
- Fresenius Kabi USA, LLC, Lake Zurich, IL
- Quantity
- 93,000 vials
- Distribution
- Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- July 28, 2015
- Terminated
- March 8, 2016
Related products
- Hydralazine Hydrochloride – drug information
- NDC 63323-614 Hydralazine Hydrochloride · Hydralazine Hydrochloride 20 mg/mL · Fresenius Kabi USA, LLC